Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors

Mise à jour : Il y a 4 ans
Référence : NCT00695032

Femme et Homme

  • | Pays :
  • France
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

RATIONALE: Studying samples of blood and urine from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is evaluating kidney damage in patients receiving cisplatin and ifosfamide for solid tumors.


Critère d'inclusion

  • Chemotherapeutic Agent Toxicity ,Renal Toxicity ,Unspecified Adult Solid Tumor, Protocol Specific

Liens